Renaissance of Allostery to Disrupt Protein Kinase Interactions

被引:38
作者
Leroux, Alejandro E. [1 ]
Biondi, Ricardo M. [1 ,2 ,3 ,4 ]
机构
[1] Consejo Nacl Invest Cient & Tecn, Inst Invest Biomed Buenos Aires IBioBA, Partner Inst, Max Planck Soc, C1425FQD, Buenos Aires, DF, Argentina
[2] Goethe Univ, Univ Hosp, Dept Internal Med 1, Theodor Stern Kai 7, D-60590 Frankfurt, Germany
[3] DKTK German Canc Consortium DKTK, Frankfurt, Germany
[4] German Canc Res Ctr, Heidelberg, Germany
关键词
PIF-BINDING POCKET; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; TYROSINE KINASE; AURORA-A; REGULATORY INTERACTIONS; CATALYTIC SUBUNIT; ACTIVATION; PDK1; INHIBITORS;
D O I
10.1016/j.tibs.2019.09.007
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Protein-protein interactions often regulate the activity of protein kinases by allosterically modulating conformation of the ATP-binding site. Bidirectional allostery implies that reverse modulation (i.e., from the ATP-binding site to the interaction and regulatory sites) must also be possible. Here, we review both the allosteric regulation of protein kinases and recent worl. describing how compounds binding at the ATP-binding site can promote or inhibit protein kinase interactions at regulatory sites via the reverse mechanism. Notably, the pharmaceutical industry has been developing compounds that bind to the ATP-binding site of protein kinases and potently disrupt protein-protein interactions between target protein kinases and their regulatory interacting partners. Learning to modulate allosteric processes will facilitate the development of protein-protein interaction modulators.
引用
收藏
页码:27 / 41
页数:15
相关论文
共 74 条
  • [1] The structure of P-TEFb (CDK9/cyclin T1), its complex with flavopiridol and regulation by phosphorylation
    Baumli, Sonja
    Lolli, Graziano
    Lowe, Edward D.
    Troiani, Sonia
    Rusconi, Luisa
    Bullock, Alex N.
    Debreczeni, Judit E.
    Knapp, Stefan
    Johnson, Louise N.
    [J]. EMBO JOURNAL, 2008, 27 (13) : 1907 - 1918
  • [2] Structural basis of Aurora-A activation by TPX2 at the mitotic spindle
    Bayliss, R
    Sardon, T
    Vernos, I
    Conti, E
    [J]. MOLECULAR CELL, 2003, 12 (04) : 851 - 862
  • [3] Switching Aurora-A kinase on and off at an allosteric site
    Bayliss, Richard
    Burgess, Selena G.
    McIntyre, Patrick J.
    [J]. FEBS JOURNAL, 2017, 284 (18) : 2947 - 2954
  • [4] The PIF-binding pocket in PDK1 is essential for activation of S6K and SGK, but not PKB
    Biondi, RM
    Kieloch, A
    Currie, RA
    Deak, M
    Alessi, DR
    [J]. EMBO JOURNAL, 2001, 20 (16) : 4380 - 4390
  • [5] High resolution crystal structure of the human PDK1 catalytic domain defines the regulatory phosphopeptide docking site
    Biondi, RM
    Komander, D
    Thomas, CC
    Lizcano, JM
    Deak, M
    Alessi, DR
    van Aalten, DMF
    [J]. EMBO JOURNAL, 2002, 21 (16) : 4219 - 4228
  • [6] Identification of a pocket in the PDK1 kinase domain that interacts with PIF and the C-terminal residues of PKA
    Biondi, RM
    Cheung, PCF
    Casamayor, A
    Deak, M
    Currie, RA
    Alessi, DR
    [J]. EMBO JOURNAL, 2000, 19 (05) : 979 - 988
  • [7] Substrate-Selective Inhibition of Protein Kinase PDK1 by Small Compounds that Bind to the PIF-Pocket Allosteric Docking Site
    Busschots, Katrien
    Lopez-Garcia, Laura A.
    Lammi, Carmen
    Stroba, Adriana
    Zeuzem, Stefan
    Piiper, Albrecht
    Alzari, Pedro M.
    Neimanis, Sonja
    Arencibia, Jose M.
    Engel, Matthias
    Schulze, Jorg O.
    Biondi, Ricardo M.
    [J]. CHEMISTRY & BIOLOGY, 2012, 19 (09): : 1152 - 1163
  • [8] Allostery and the Monod-Wyman-Changeux Model After 50 Years
    Changeux, Jean-Pierre
    [J]. ANNUAL REVIEW OF BIOPHYSICS, VOL 41, 2012, 41 : 103 - 133
  • [9] 50th anniversary of the word "Allosteric"
    Changeux, Jean-Pierre
    [J]. PROTEIN SCIENCE, 2011, 20 (07) : 1119 - 1124
  • [10] International Union of Basic and Clinical Pharmacology. XC. Multisite Pharmacology: Recommendations for the Nomenclature of Receptor Allosterism and Allosteric Ligands
    Christopoulos, Arthur
    Changeux, Jean-Pierre
    Catterall, William A.
    Fabbro, Doriano
    Burris, Thomas P.
    Cidlowski, John A.
    Olsen, Richard W.
    Peters, John A.
    Neubig, Richard R.
    Pin, Jean-Philippe
    Sexton, Patrick M.
    Kenakin, Terry P.
    Ehlert, Frederick J.
    Spedding, Michael
    Langmead, Christopher J.
    [J]. PHARMACOLOGICAL REVIEWS, 2014, 66 (04) : 918 - 947